FARABEGOLI, FULVIA

FARABEGOLI, FULVIA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

FARABEGOLI F.; F .FARABEGOLI; FARABEGOLI FU  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.058 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di... Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli 2023-01-01 - FEBS PRESS 4.03 Poster -
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer Myers S. H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipan...i F., Ortega Martínez J. A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A. 2023-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista AN19FN~1.PDF1-s2.0-S0223523423010814-mmc1.docx
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials Emanuela Mensà, Ottavia Tartagni, Fulvia Farabegoli, Renato Brandimarti, Dario De Biase, Giampaol...o Zuccheri 2023-01-01 - - 4.02 Riassunto (Abstract) -
Proteomic profile of BxPC-3 cells after treatment with BRC4 Viola Previtali, Samuel H. Myers, Laura Poppi, Kieran Wynne, Irene Casamassima Stefania Girotto, ...Giuseppina Di Stefano, Fulvia Farabegoli, Marinella Roberti, Giorgio Oliviero, Andrea Cavalli 2023-01-01 JOURNAL OF PROTEOMICS - 1.01 Articolo in rivista -
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement Carmen Ciavarella, Ilenia Motta, Santino Blando, Sabrina Valente, Fulvia Farabegoli, Maria Letizi...a Focarete, Mauro Gargiulo, Gianandrea Pasquinelli 2022-01-01 BIOMEDICINES - 1.01 Articolo in rivista biomedicines-10-01276-v2.pdf
Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines Farabegoli F.; Granja A.; Magalhaes J.; Purgato S.; Voltattorni M.; Pinheiro M. 2022-01-01 ACS OMEGA - 1.01 Articolo in rivista acsomega.2c01829(2022).pdf
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy Farabegoli, Fulvia; Pinheiro, Marina 2022-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-13-809706.pdf
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells Rossi V.; Govoni M.; Farabegoli F.; Di Stefano G. 2022-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS - 1.01 Articolo in rivista Revised Manuscript.pdf
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination Schipani, Fabrizio; Manerba, Marcella; Marotta, Roberto; Poppi, Laura; Gennari, Arianna; Rinaldi,... Francesco; Armirotti, Andrea; Farabegoli, Fulvia; Roberti, Marinella; Di Stefano, Giuseppina; Rocchia, Walter; Girotto, Stefania; Tirelli, Nicola; Cavalli, Andrea 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-23-08338-v3 (1).pdf
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) Petrocelli, Giovannamaria; Farabegoli, Fulvia; Valerii, Maria Chiara; Giovannini, Catia; Sardo, A...lberto; Spisni, Enzo 2021-01-01 MOLECULES - 1.01 Articolo in rivista molecules-26-00885.pdf
EGCG mediated targeting of deregulated signaling pathways and non-coding rnas in different cancers: Focus on JAK/STAT, Wnt/β-catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL mediated signaling pathways Farooqi A.A.; Pinheiro M.; Granja A.; Farabegoli F.; Reis S.; Attar R.; Sabitaliyevich U.Y.; Xu B....; Ahmad A. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-00951.pdf
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib Bagnolini G.; Milano D.; Manerba M.; Schipani F.; Ortega J.A.; Gioia D.; Falchi F.; Balboni A.; F...arabegoli F.; De Franco F.; Robertson J.; Pellicciari R.; Pallavicini I.; Peri S.; Minucci S.; Girotto S.; Di Stefano G.; Roberti M.; Cavalli A. 2020-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista ASAP_acs.jmedchem.9b01526.pdf
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells Marinella Roberti, Fabrizio Schipani, Greta Bagnolini, Domenico Milano, Elisa Giacomini, Federico... Falchi, Andrea Balboni, Marcella Manerba, Fulvia Farabegoli, Francesca De Franco, Janet Robertson, Saverio Minucci, Isabella Pallavicini, Giuseppina Di Stefano, Stefania Girotto, Roberto Pellicciari, and Andrea Cavalli 2019-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -
Epigallocatechin-3-gallate and 6-OH-11-O-hydroxyphenanthrene limit BE(2)-C neuroblastoma cell growth and neurosphere formation in vitro Farabegoli, Fulvia*; Govoni, Marzia; Spisni, Enzo; Papi, Alessio 2018-01-01 NUTRIENTS - 1.01 Articolo in rivista nutrients-10-01141.pdf
Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells Farabegoli, F.; Scarpa, E.S.; Frati, A.; Serafini, G.; Papi, A.; Spisni, E.; Antonini, E.; Benede...tti, S.; Ninfali, P 2017-01-01 FOOD CHEMISTRY - 1.01 Articolo in rivista Farabegoli2017Copertina_GENERICA_UNIBO_postprint_IRIS-1.pdf
EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion Farabegoli, Fulvia; Govoni, Marzia; Spisni, Enzo; Papi, Alessio 2017-01-01 BIOSCIENCE REPORTS - 1.01 Articolo in rivista BSR20170168.full.pdf
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors Falchi, Federico; Giacomini, Elisa; Masini, Tiziana; Boutard, Nicolas; Di Ianni, Lorenza; Manerba..., Marcella; Farabegoli, Fulvia; Rossini, Lara; Robertson, Janet; Minucci, Saverio; Pallavicini, Isabella; Di Stefano, Giuseppina; Roberti, Marinella; Pellicciari, Roberto; Cavalli, Andrea 2017-01-01 ACS CHEMICAL BIOLOGY - 1.01 Articolo in rivista -
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines Papi, Alessio; Govoni, Marzia; Ciavarella, Carmen; Spisni, Enzo; Orlandi, Marina; Farabegoli, Fulvia 2016-01-01 CURRENT CANCER DRUG TARGETS - 1.01 Articolo in rivista -
A RXR ligand 6-OH-11-O-hydroxyphenanthrene with antitumour properties enhances (-)-epigallocatechin-3-gallate activity in three human breast carcinoma cell lines. Farabegoli F; Govoni M; Ciavarella C; Orlandi M; Papi A. 2014-01-01 BIOMED RESEARCH INTERNATIONAL - 1.01 Articolo in rivista BMRI2014.pdf853086.pdf
Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells A. Papi; F. Farabegoli; R. Iori; M. Orlandi; G.R. De Nicola; M. Bagatta ; D. Angelino; L. Gennari...; P. Ninfali 2013-01-01 FOOD CHEMISTRY - 1.01 Articolo in rivista -